Table 1 |
||
| Clinical and sociodemographic data (N = 242) | ||
| Frequency (%) | ||
| Age | Median (SD) | 65.00 y (8.3y) |
| Range | 40-84y | |
| Marital status | Single | 18 (8.4%) |
| Partnership, marriage | 135 (63.1%) | |
| Divorced, separated | 28 (13.1%) | |
| Widowed | 33 (15.4%) | |
| Employment status | Full-time | 16 (7.5%) |
| Part-time | 16 (7.5%) | |
| Unemployed | 5 (2.1%) | |
| Homemaker | 31 (14.5%) | |
| Retired | 142 (66.4%) | |
| Other | 4 (1.6%) | |
| Histological classification | Invasive | 226 (93.4%) |
| In situ | 15 (6.2%) | |
| Missing | 1 (0.4%) | |
| Grading | Grade I | 35 (14.5%) |
| Grade II | 176 (72.7%) | |
| Grade III | 10 (4.1%) | |
| Unknown | 21 (8.7%) | |
| Duration of adjuvant endocrine therapy (months) | Median (SD) | 26.7 (19.1) mo. |
| Range | 0.7- 89.5 mo. | |
| Primary surgical treatment | Breast-conserving procedure | 155 (65.7%) |
| Mastectomy | 81 (34.3%) | |
| Reconstruction | 43 (18.2%) | |
| Chemotherapy | 41 (16.9%) | |
| Radiotherapy | 169 (71.3%) | |
Oberguggenberger et al. BMC Cancer 2012 12:474 doi:10.1186/1471-2407-12-474
